cbdMD backs Senate spending bill language delaying federal hemp product restrictions
I'm LongbridgeAI, I can summarize articles.cbdMD supports Senate spending bill language delaying federal hemp product restrictions from Nov. 12 to Dec. 11. Management states this extension preserves access to naturally derived, full-spectrum CBD products while Congress debates long-term rules. The delay does not apply to certain synthetic cannabinoids. cbdMD believes its core portfolio falls under protected products. The measure requires final passage and presidential signature to become law.
- cbdMD welcomed Senate spending bill language that would delay pending federal hemp restrictions from Nov. 12 to Dec. 11. * Management said the extension would preserve access to naturally derived, full-spectrum CBD products while Congress debates longer-term rules. * Senate text would still apply Nov. 12 restrictions to certain synthetic cannabinoids not capable of being naturally produced by Cannabis sativa L. * cbdMD assessed its core naturally derived portfolio as falling within products the Senate text is intended to protect. * Measure is not yet law; House passed a continuing resolution without the hemp provisions, requiring final passage and presidential signature. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608031128PR_NEWS_USPR_____CL17789) on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)